Sun Pharmaceutical Industries Share Price

ABOUT Sun Pharmaceutical Industries

• Industry Biotechnology & Drugs
• ISIN INE044A01036
• BSE Code 524715
• NSE Code SUNPHARMA

Sun Pharmaceutical Industries Limited is an India-based specialty generic pharmaceutical company with a presence in specialty, generics and consumer healthcare products. It is engaged in manufacturing, developing, and marketing a range of branded and generic formulations and active pharmaceutical ingredients (APIs). It produces a diverse and complementary portfolio of generic and specialty medicines targeting a wide spectrum of chronic and acute treatments. It offers a variety of dosage forms, including orals, creams, ointments, injectables, sprays, and liquids. Its global specialty portfolio spans advanced products in dermatology, ophthalmology, and onco-dermatology. Its marketed specialty portfolio includes Ilumya/ Ilumetri, Winlevi, Levulan Kerastick + BLU-U, Absorica LD, Odomzo, Cequa, Bromsite, Xelpros, and others. Its vertically integrated operations deliver medicines to physicians and consumers in over 100 countries. Its manufacturing facilities are spread across six continents.

MANAGEMENT

• Dilip Shanghvi Chairman, Managing Director, Executive Director
• C. S. Muralidharan Chief Financial Officer
• Aalok Shanghvi Whole-time Director, Executive Vice-President, Emerging Markets, Global generic R&D, Global BD (Generics Segment) & API
• Anoop Deshpande Compliance Officer, Company Secretary